Blog
American Liver Foundation (ALF) is thrilled to announce the recipients of its 2026 Pilot Research Awards to support 14 early-career investigators who […]
ALF announces Michael Karin, PhD, as the recipient of its prestigious 2026 Distinguished Scientific Achievement Award, recognizing his nearly five decades of research on the biological pathways that connect inflammation, metabolic disease and liver cancer.
American Liver Foundation (ALF) is proud to once again be a member of the TCS New York City Marathon Charity Program, for the 2026 race, which takes place on Sunday, November 1. Runners will complete 26.2 miles through New York City’s five boroughs.
American Liver Foundation (ALF) is pleased to announce that Pro Football Hall of Famer Dan Marino was the keynote speaker at its 50th Anniversary National Legacy Gala on Wednesday, Oct. 28 at Gotham Hall in New York City.
American Liver Foundation (ALF) hosted its MASH: Empower and Educate Summit on Friday, Oct. 16 and Saturday, Oct. 17 at the Sheraton Grand Chicago Hotel, bringing together 30 patients from across the country who live with metabolic dysfunction-associated steatohepatitis (MASH) or metabolic dysfunction-associated steatotic liver disease (MASLD).
American Liver Foundation (ALF) will commemorate five decades of service to patients and families as well as medical professionals and leading organizations at its 50th Anniversary National Legacy Gala on Wednesday, Oct. 28, at Gotham Hall in New York City.
American Liver Foundation (ALF) is proud to once again be among the more than 200 non-profits participating as a member of the 2026 Bank of America Chicago Marathon Official Charity Program this Sunday, October 11.
An estimated 80 to 100 million Americans have liver disease, but many don’t know it because early symptoms can be subtle. October is National Liver Awareness Month and Liver Cancer Month and ALF is raising awareness and connecting people with vital resources. Take ALF’s one-minute quiz to understand your risk for liver disease, liver cancer or both.
American Liver Foundation (ALF) is excited to announce the appointment of four new board members to its National Board of Directors – Alexander Kerr, Founder of Trajektory; Michael Kim, Portfolio Manager at Fidelity Investments; Kerry Schneider, Director of Events, at GSE Worldwide; and Gordon Scott, Managing Director and Portfolio Manager, at CIBC Asset Management.
American Liver Foundation’s (ALF) Liver Life Advocacy Summit was held in Washington, D.C. on April 21st and 22nd and brought together patients, caregivers and families from coast to coast to champion legislative priorities for liver health and help the 100 million Americans affected by liver disease.
American Liver Foundation (ALF) is proud to once again be a member of the 130th Boston Marathon® presented by Bank of America, which takes place on Monday, April 20, 2026, at Hopkinton to Boston.
American Liver Foundation (ALF) will bring together patients, caregivers, and family members affected by liver disease from across the country for the Liver Life Advocacy Summit™ in Washington, D.C., on Tuesday, April 21 and Wednesday April 22 to champion ALF’s 2026 legislative priorities and advance liver health.